Wolverine Trading’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$88.4M Buy
191,300
+133,900
+233% +$62.3M 0.06% 208
2025
Q2
$23.4M Buy
57,400
+19,100
+50% +$7.99M 0.02% 427
2025
Q1
$19.2M Sell
38,300
-26,400
-41% -$14.3M 0.02% 417
2024
Q4
$33.6M Buy
64,700
+6,800
+12% +$3.74M 0.03% 324
2024
Q3
$35.6M Buy
57,900
+1,700
+3% +$1.01M 0.04% 275
2024
Q2
$31.1M Sell
56,200
-11,100
-16% -$6.36M 0.03% 294
2024
Q1
$39.1M Sell
67,300
-22,900
-25% -$12.9M 0.04% 240
2023
Q4
$47.9M Buy
90,200
+26,400
+41% +$12.8M 0.05% 224
2023
Q3
$32.3M Buy
63,800
+900
+1% +$480K 0.03% 245
2023
Q2
$32.4M Sell
62,900
-16,300
-21% -$8.8M 0.04% 242
2023
Q1
$44.6M Buy
79,200
+10,100
+15% +$5.69M 0.07% 167
2022
Q4
$38.1M Sell
69,100
-6,900
-9% -$3.66M 0.06% 252
2022
Q3
$39.3M Buy
76,000
+17,900
+31% +$10M 0.06% 168
2022
Q2
$31.1M Sell
58,100
-11,300
-16% -$6.22M 0.05% 207
2022
Q1
$41.3M Sell
69,400
-58,000
-46% -$33.3M 0.05% 229
2021
Q4
$84.8M Buy
127,400
+3,600
+3% +$2.25M 0.1% 122
2021
Q3
$71.8M Buy
123,800
+21,600
+21% +$11.9M 0.08% 159
2021
Q2
$51.9M Buy
102,200
+38,700
+61% +$18.3M 0.08% 181
2021
Q1
$28.7M Sell
63,500
-41,200
-39% -$19.7M 0.04% 287
2020
Q4
$48.3M Buy
104,700
+52,500
+101% +$24.6M 0.08% 168
2020
Q3
$22.7M Buy
52,200
+5,300
+11% +$2.19M 0.06% 260
2020
Q2
$16.5M Sell
46,900
-8,800
-16% -$2.95M 0.04% 304
2020
Q1
$15.9M Sell
55,700
-33,800
-38% -$10.7M 0.05% 291
2019
Q4
$29.1M Buy
89,500
+9,000
+11% +$2.73M 0.07% 228
2019
Q3
$23.1M Buy
80,500
+11,600
+17% +$3.32M 0.07% 239
2019
Q2
$20.2M Sell
68,900
-12,800
-16% -$3.53M 0.06% 283
2019
Q1
$22.4M Buy
81,700
+16,100
+25% +$4.01M 0.06% 228
2018
Q4
$14.6M Buy
65,600
+8,900
+16% +$2.09M 0.04% 337
2018
Q3
$13.8M Sell
56,700
-9,000
-14% -$2.07M 0.03% 427
2018
Q2
$13.6M Hold
65,700
0.03% 377
2018
Q1
$13.6M Buy
65,700
+4,000
+6% +$840K 0.03% 377
2017
Q4
$11.7M Sell
61,700
-7,700
-11% -$1.48M 0.04% 437
2017
Q3
$13.1M Buy
+69,400
New +$12.6M 0.05% 327
2017
Q1
Sell
-91,200
Closed -$12.9M 4983
2016
Q4
$12.9M Sell
91,200
-11,500
-11% -$1.7M 0.06% 310
2016
Q3
$16M Buy
+102,700
New +$15.8M 0.07% 295

Other funds holding TMO

Wolverine Trading's TMO Position: Q3 2025 in Review

Wolverine Trading sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 8,682 shares — an estimated $4.04M sold.

Wolverine Trading first reported a position in TMO in Q3 2017 and held it in 30 quarters. The position peaked at $68.6M in Q4 2023. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Wolverine Trading reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 8,682 Thermo Fisher Scientific shares in Q3 2025, an estimated $4.04M.
  • Wolverine Trading first reported a position in Thermo Fisher Scientific in Q3 2017 and held it in 30 quarters.
  • Wolverine Trading's Thermo Fisher Scientific position peaked at $68.6M in Q4 2023.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.